Detectability of early brain meningitis with magnetic resonance imaging
Journal Article
·
· Investigative Radiology
- Univ. of Kentucky, Lexington, KY (United States)
The ability of high-field (1.5 T) magnetic resonance imaging (MRI) to detect early brain meningitis was evaluated in a canine model. Contrast dose, timing postinjection, and imaging technique (specifically the use of magnetization transfer) were assessed. Imaging of five canines was performed at 1.5 T 24 hours after injection of Cowans staphylococcus into the cisterna magna. Two control animals also were imaged using the same protocol. Contrast doses of 0.1, 0.3, and 0.8 mmol/kg gadoteridol were compared. Scans were performed at 2, 13, and 22 minutes after an initial injection of 0.1 mmol/kg. Thirty minutes after the initial injection of contrast, a supplemental dose of 0.2 mmol/kg was given. Scans were then repeated at 2, 12, and 22 minutes after this dose was administered. A second supplemental contrast injection of 0.5 mmol/kg was given at 70 minutes, and immediate postinjection scans with and without MT were acquired. Results. In the animals receiving a cisternal injection of bacteria, the degree of meningeal enhancement was greatest at 0.8 mmol/kg, intermediate at 0.3 mmol/kg, and least at 0.1 mmol/kg. Scans in control studies did not demonstrate abnormal meningeal enhancement. High-contrast dose, MT, and acquisition of immediate postcontrast scans all resulted in statistically significant improvement. On masked film review, abnormal meningeal enhancement was noted in only 2 of 5 experimental dogs at a dose of 0.1 mmol/kg (regardless of the use of MT) compared with all animals at a dose of 0.3 mmol/kg. In 18 of 37 dogs (paired scans with and without MT), when abnormal enhancement was noted, the use of MT improved the visualization of abnormal meningeal enhancement. In early brain meningitis, high-contrast dose (0.3 mmol/kg), MT, and scanning immediately after injection improve detection of abnormal meningeal enhancement, thus facilitating the diagnosis of meningitis. Of these factors, contrast dose is the most important. 14 refs., 9 figs., 2 tabs.
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 160129
- Journal Information:
- Investigative Radiology, Journal Name: Investigative Radiology Journal Issue: 8 Vol. 30; ISSN 0020-9996; ISSN INVRAV
- Country of Publication:
- United States
- Language:
- English
Similar Records
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases
Comparison of gadolinium Cy{sub 2}DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease
Gadopentetate dimeglumine-enhanced MR of the brain: Clinical utility and safety in patients younger than two years of age
Journal Article
·
Wed Jun 01 00:00:00 EDT 1994
· AJNR. American Journal of Neuroradiology
·
OSTI ID:50617
Comparison of gadolinium Cy{sub 2}DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease
Journal Article
·
Tue Jan 31 23:00:00 EST 1995
· Investigative Radiology
·
OSTI ID:79381
Gadopentetate dimeglumine-enhanced MR of the brain: Clinical utility and safety in patients younger than two years of age
Journal Article
·
Wed Jun 01 00:00:00 EDT 1994
· AJNR. American Journal of Neuroradiology
·
OSTI ID:50616